| ADP | Adenosine diphosphate |
| ALA | Alpha-linolenic acid |
| ALX/FPR2 | Lipoxin A receptor/formyl peptide receptor 2 |
| ARA | Arachidonic acid |
| ASA | Acetylsalicylic acid |
| ATP | Adenosine triphosphate |
| EPA | Eicosapentaenoic acid |
| ChemR23 | Chemerin receptor 23 |
| CMKLR1 | Chemokine-like receptor 1 |
| COX1 | Cyclooxygenase 1 |
| COX2 | Cyclooxygenase 2 |
| CYP450 | Cytochromes P450 |
| DHA | Docosahexaenoic acid |
| DPA | Docosapentaenoic acid |
| DOMS | Delayed onset muscle soreness |
| DRV1 | Resolvin D receptor 1 |
| ERV | E series receptor |
| FOR | Functional overreaching |
| GPR32 | G protein-coupled receptor 32 |
| GPR37 | G protein-coupled receptor 37 |
| IFNγ | Interferon-γ |
| IGF1 | Insulin-like growth factor 1 |
| IL6 | Interleukin 6 |
| IL8 | Interleukin 8 |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| LAT-1 | L-amino acid transporter |
| LGR6 | Leucine-rich repeat-containing G protein-coupled receptor 6 |
| MCTR1 | Maresin conjugates in tissue regeneration 1 |
| MCTR2 | Maresin conjugates in tissue regeneration 2 |
| MCTR3 | Maresin conjugates in tissue regeneration 3 |
| MPS | Muscle protein synthesis |
| mTOR | Mechanistic target of rapamycin |
| nrf2 | Nuclear factor erythroid 2-like 2 |
| ONS | Oral nutritional supplement |
| Pax7 | Paired box 7 |
| PGC-1α | Peroxisome proliferator-activated receptor gamma co-activator 1-alpha |
| PGF2 | Prostaglandin 2 |
| PPARs | Peroxisome proliferator-activated receptors |
| PUFAs | Polyunsaturated fatty acids |
| RORα | RAR-related orphan receptor alpha |
| RT | Reaction time |
| SPMs | Specialized pro-resolving mediators |
| TLR4 | Toll-like receptor 4 |
| TNF-α | Tumor necrosis factor α |
| VO2 max | Maximal oxygen consumption |
| 5-LOX | Lipoxygenase 5 |
| 12-LOX | Lipoxygenase 12 |
| 15-LOX | Lipoxygenase 15 |